Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 885-891

  Silva, Katia C ^a   Rosa, Maria Luiza Garcia ^b   Moyses, Natalia ^a   Afonso, Larissa A ^a   Oliveira, Ledy H S ^a   Cavalcanti, Silvia M B ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

Author keywords

Age; HPV; Papanicolaou; PCR; Risk factors; Sexual partners

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; NICOTIANA TABACUM;

EID: 70350284641     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000600011     Document Type: Article

References (24)

1. Baseman JG, Koutsky LA 2005. The epidemiology of human papillomavirus infections. J Clin Virol 32S: 16-24.
2. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR 1993. Determinants of genital human papillomavirus infection in low risk women in Portland, Oregon. Sex Trans Dis 20: 274-278.
3. Bosch FX, Sanjosé S 2003. Human papillomavirus and cervical cancer-burden and assessment of causality. Monographs J Nat Cancer Inst 31: 3-13.
4. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R 1996. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174: 679-689.
5. Cavalcanti SMB, Zardo LG, Oliveira LHS 2000. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infection 40: 80-87.
6. Clifford GM, Gallus S, Herrero R, Muñoz n, Snidjers PFJ, Ferrecio C, Hieu nT, Franceschi S 2005. Worldwide distribution of human papillomavirus in cytologically normal women in IARC: a pooled-analysis. Lancet 366: 991-998.
7. Coutinho LMS, Scazufca M, Menezes PR 2008. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica 42: 1-6.
8. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C 2004. Multiple high-risk infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57: 68-72.
9. Ferenczy A, Coutlée F, Franco E, Hankins C 2003. Human papillomavirus and HIV co-infection and risk of neoplasias of the lower genital tract. A review of recent developments. Can Med Assoc J 169: 1-19.
10. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G 1999. Desing and methods of the Ludwing-Mc Gill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Pan Am J Public Health 6: 223-233.
11. Giuliano AP, Harris R, Sedjo RL 2002. Incidence, prevalence and clearance of type-specific HPV infections. J Infect Dis 186: 462-469.
12. Heilmann V, Kreienberg R 2002. Molecular biology of cervical cancer and its precursors. Curr Womens Health Rep 2: 27-33.
13. Ho GY, Bierman R, Beardsley L, Chang C, Burk RD 1988. natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423-428.
14. InCA - Instituto nacional de Câncer 2008. Estimativa de incidência e mortalidade por câncer no Brasil. Available from: http://www. inca.org.br.
15. Jones SB 1999. Cancer in developing world: a call to action. BMJ 319: 505-508.
16. Lepique AP, Rabachini T, Villa LL 2009. HPV vaccination: the beginning of the end of cervical cancer? A review. Mem Inst Oswaldo Cruz 104: 1-10.
17. Muñoz n, Kato I, Bosch FX, Eluf-neto J, de San Jose S 1996. Risk factors for HPV detection in middle-aged women. Sex Transm Dis 23: 504-510.
18. naud P, Matos J, Hammes L, Stuckzynski J, Brouwers K, Magno V, Dias E, Crusius P, Campos C, Hoblik M, Marroni R, Syrjanen K 2006. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur J Obstet Gynecol 12: 110-118.
19. Oliveira FA, Pleger V, Lang K, Heukelbach J, Miralles I, Fraga F, Souza AQ, Stoffler-Meilicke M, Ignatius R, Kerr LFS, Feldmeier H 2007. Sexually transmitted infections, bacterial vaginosis and candidiasis in women of reproductive age in rural northeast Brazil: a population-based study. Mem Inst Oswaldo Cruz 102: 751-756.
20. Pereira CR, Rosa MLG, Vasconcellos GAL, Cavalcanti SMB, Oliveira LHS 2007. Human papillomavirus prevalence and predictors to cervical cancer among high risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer 17: 651-660.
21. Stern PL 2005. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J Clin Virol 32: 48-57.
22. Syrjanen S, Shabalova IP, Petrovichev N 2003. Sexual habits and human papillomavirus infections smong women of three new independent states of former Soviet Union. Sex Transm Dis 30: 680-684.
23. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL 2000. Molecular variants of human papillomavirus types 16 and 18 prefentially associated with cervical neoplasia. J Gen Virol 81: 2959-2968.
24. Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MCl 2003. Seroprevalence of HPV 16, 18, 31 and 45 in a population-based cohort of 10,000 women from Costa Rica. Br J Cancer 89: 1248-1254.